Breadcrumb
Main navigation (Sidebar Template)
-
Policy & Compliance
-
Implementation of New Initiatives and Policies
-
NIH Grants and Funding Information Status
-
Common Forms for Biographical Sketch and Current and Pending (Other) Support
-
Simplified Review Framework for Most Research Project Grants (RPGs)
-
Revisions to the NIH Fellowship Application and Review Process
-
Updates to Finding NIH Funding Opportunities and Information
-
Updates to NIH Institutional Training Grant Applications
-
Reference Letters
-
Updated Application Forms and Instructions (FORMS-I)
-
NIH Grants and Funding Information Status
-
Grants Policy Statement
-
Notices of Policy Changes
-
Compliance & Oversight
-
Policy Topics
-
Animal Welfare
-
Animals in NIH Research
-
Why Animals are Used in Research
-
How Animals Have Helped Improve Public Health
-
Adoption/Rehoming/Retirement of Laboratory Animals after Research
-
Why Properly Designed Experiments are Critical to Animal Research and Advancing Public Health
-
Ensuring the Care of Research Animals
-
When Are Alternatives to Animals Used in Research
-
Why Animals are Used in Research
-
Clinical Trial Requirements for Grants and Contracts
-
NIH's Definition of a Clinical Trial
-
Decision Tool: Does Your Human Subjects Study Meet the NIH Definition of a Clinical Trial?
-
Is My Project a Clinical Trial, Basic Experimental Study Involving Humans (BESH), or an Observational Study Involving Humans?
-
Basic Experimental Studies Involving Humans (BESH)
-
Clinical Trial-Specific Funding Opportunities
-
Clinical Trial-Specific Review Criteria
-
Good Clinical Practice Training
-
Human Subjects System
-
Human Subjects and Clinical Trials Information Form
-
Posting Clinical Trial Informed Consent Forms
-
Protocol Templates for Clinical Trials
- Requirements for Registering & Reporting NIH-Funded Clinical Trials
-
Information about NIH Clinical Trial Stewardship
-
Training & Resources for NIH Clinical Trial Policies
-
NIH's Definition of a Clinical Trial
-
Communicating, and Acknowledging Federal Funding
-
Early Stage Investigator Policies
-
NIH Early Stage Investigators Policy
-
Determining Early Stage Investigator (ESI) Status
-
Early Stage Investigator Extensions
-
Early Stage Investigator Related Data
-
History of NIH Support for Early Career Investigators
-
Related Notices, Laws, Statements and Reports
-
List of Smaller Grants & Awards that Maintain ESI Status
-
NIH Early Stage Investigators Policy
-
Family-Friendly Initiatives
- Financial Conflict of Interest
- Foreign Interference
-
Human Subjects Research
- Definition of Human Subjects Research
- Pre-Award and Post-Award Processes for Projects Involving Human Subjects Research
- Certificates of Confidentiality
-
Clinical Trial Requirements for Grants and Contracts
-
Inclusion Policies for Human Subjects Research
- Single IRB for Multi-Site or Cooperative Research
- Policies & Regulations for Human Subjects
-
Training & Resources for Human Subjects
- Inclusion Policies for Human Subjects Research
- Intellectual Property Policy
-
Lobbying Guidance for Recipient Activities
-
Natural Disasters
-
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
-
Applicant/Recipient COVID-19 Update History
-
Funding Opportunities Specific to COVID-19
-
NIH Implementation of OMB Memorandum M-20-26 “Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated June 18, 2020
-
Review Process during COVID-19 Pandemic
-
The Impact of COVID-19 on the Research Community
-
Applicant/Recipient COVID-19 Update History
-
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- Next Generation Researchers Initiative
- NIH Fiscal Policies
-
Peer Review Policies and Practices
- Public Access
- Research Integrity
- Research Misconduct
-
Rigor and Reproducibility
-
Principles and Guidelines for Publishing Preclinical Research
-
Guidance: Rigor and Reproducibility in Grant Applications
-
Resources for Preparing Your Application
-
Training and Other Resources for Rigor and Reproducibility
-
Meetings and Workshops for Rigor and Reproducibility
-
Notices, Blog Posts, and References for Rigor and Reproducibility
-
Principles and Guidelines for Publishing Preclinical Research
-
Scientific Data Sharing: Policies and Access to Data
-
Data Management and Sharing Policy
-
Genomic Data Sharing Policy
-
Genomic Data Sharing Policy Overview
-
Developing Genomic Data Sharing Plans
-
About Institutional Certifications
-
Completing an Institutional Certification Form
-
Genomic Data Sharing Expectations by NIH Institute & Center
-
Data Submission and Release Expectations
-
Where to Submit Genomic Data
-
How to Register and Submit a Study in dbGaP
-
GDS IC Contacts
-
Genomic Data Sharing Policy Overview
- Other Sharing Policies
-
Accessing Data & Publications
-
Requirements for NIH Controlled-Access Data Repositories and Users
-
Accessing Scientific Data
-
Accessing Genomic Data from NIH Repositories
-
How to Request and Access Datasets from dbGaP
-
Using Genomic Data Responsibly Under the NIH Genomic Data Sharing Policy
-
Genomic Data User Code of Conduct
-
NIH Data Use Certification Agreement
-
Requirements for NIH Controlled-Access Data Repositories and Users
-
Which Sharing Policies Apply to My Research?
-
Data Management and Sharing Policy
-
Select Agent Information
-
Subawards
-
Submission Policies
-
Supporting a Safe and Respectful Workplace
-
Animal Welfare
-
Implementation of New Initiatives and Policies
ICO Funding Policies and Considerations
NIH uses a unified funding strategy when making funding decisions. A set of core tenets provide a framework for all institute, center and office (ICO) funding policies to support the most meritorious science, address health priorities, and support a robust biomedical workforce.
Core Tenets
- Align with the NIH's mission
- Prioritize scientific merit; ICOs should consider peer review information in its entirety
- Integrate a breadth of topics and approaches relevant to the ICO’s priorities
- Consider investigator career stage and promote sustainability of the biomedical research workforce
- Promote broad distribution and geographic balance of funding, considering the total amount and type of NIH funding already available to each investigator
- Align with the availability of ICO funds
These ICO-specific funding policies and considerations pages build on the agency-wide framework.
- Fogarty International Center (FIC)
- National Center for Advancing Translational Sciences (NCATS)
- National Cancer Institute (NCI)
- National Eye Institute (NEI)
- National Human Genome Research Institute (NHGRI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Biomedical Imaging and Bioengineering (NIBIB)
- National Institute on Drug Abuse (NIDA)
- National Institute on Deafness and other Communication Disorders (NIDCD)
- National Institute of Dental and Craniofacial Research (NIDCR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Environmental Health Sciences (NIEHS)
- National Institute of General Medical Sciences (NIGMS)
- National Institute of Mental Health (NIMH)
- National Institute of Nursing Research (NINR)
- National Library of Medicine (NLM)
- Office of Behavioral and Social Sciences Research (OBSSR)
- Office of Disease Prevention (ODP)
- Office of Research Infrastructure Programs (ORIP)
- Office of Strategic Coordination (OSC)
For technical issues E-mail OER Webmaster